HUMA Humacyte, Inc.

NASDAQ
$0.50

Humacyte, Inc. (HUMA) Earnings News

Earnings press releases, previews and reviews for Humacyte, Inc. (HUMA), newest first. Our most recent is review: Humacyte Beats as Symvess Sales More Than Double, but Dilution, Negative Gross Margin and Shrinking Cash Shadow the Inflection.